American Humane is proud to accept
applications for our grant programs, which fund a spectrum of lifesaving work benefitting both humans and animals.
Not exact matches
For those non-white male students accepted into the
program — there is an
application process — Lazard
grants them $ 30,000 at first and then another $ 45,000 if they are offered an accept a full - time position at the firm.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues
for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement
for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding
for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state
grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug
applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all,
for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Primary Industries and Regions South Australia (PIRSA) are currently taking
applications for «Building South Australia's Premium Food and Wine Credentials
Grant Program — Non-GM and Organic» (Round 3).
The Massachusetts Department of Environmental Protection (MassDEP) Recycling Business Development
Grant (RBDG) program is currently accepting applications for its 2018 grant c
Grant (RBDG)
program is currently accepting
applications for its 2018
grant c
grant cycle.
The Assistance
grants — Improved access to industry priority uses of agvet chemicals
grants program is designed to help with the generation of sufficient data to support
applications to the APVMA
for agvet chemical uses identified as a priority through a collaborative process.
The Fuel Up to Play 60 (FUTP 60)
program is now accepting
grant funding
applications for California schools interested in supporting healthy school environments.
She said the park district is hoping to hear in the next two months whether its
application for a $ 233,000 stormwater management
grant from the Illinois Environmental Protection Agency's Illinois Green Infrastructure Grant program will be appr
grant from the Illinois Environmental Protection Agency's Illinois Green Infrastructure
Grant program will be appr
Grant program will be approved.
So it's great news that the U.S. Department of Agriculture has today released a «Request
for Applications» (RFA)
for a new farm - to - school
grant program.
Nika assists with
grant applications and fundraising efforts and is responsible
for the administrative procedures supporting these
programs.
Dane County Executive Kathleen Falk announced Wednesday the county is accepting
applications for two public / private
grant programs to support projects that improve and protect land and water resources.
Katko was unavailable
for comment Tuesday, but a spokeswoman said he supplied letters of support
for Syracuse's
grant applications for the lead
program and the police body cameras.
Auburn City Councilor Jimmy Giannettino speaks Tuesday at Memorial City Hall about some of the featured components in the city's
grant application for the Downtown Revitalization Initiative
program.
Manhattan Borough President Gale A. Brewer has opened the
application period
for the Manhattan Community Award
Program (MCAP)
grants to nonprofit organizations and public schools.
Off - topic questions included the mayor's proposed budget and the potential cost of open labor contracts, a timeline
for settling the open labor contracts, the Build it Back
program, the administration's «comprehensive review» of the city's Sandy recovery efforts, release of Bishop Findlayter's arrest report, the mayor's September promise to visit a carriage horse stable before acting on his pledge to ban carriage horses and the administration's community development block
grant application.
Due to a financing gap, the company later applied
for funding through Round 4 of the Regional Council Consolidated Funding
Application (CFA) process in 2014, and was awarded a $ 1.5 million Regional Council
grant and a $ 2.5 million Downstate Revitalization
Program grant.
Governor Cuomo today announced that
applications from non-profit non-public schools and day care centers, are now being accepted
for the $ 25 million Securing Communities Against Hate Crimes
Grant program,
for grants to strengthen security and prevent hate crimes or attacks... Continue reading →
------------------------- The Delaware County Tourism Advisory Board is now accepting
applications for funding under the newly created Tourism Promotion & Development
Grant program.
It also serves as a combined
application for federal funds under three (3) of the U.S. Department of Housing and Urban Development's (HUD) formula
grant programs, including CDBG, HOME, and HESG.
A $ 30 million -
grant program for communities and businesses in New York recovering from Hurricane Irene and Tropical Storm Lee is now accepting
grant applications, Empire State Development and the Department of Environmental Conservation announced this week.
SYRACUSE, N.Y. - The 20 - year - old lead abatement
program run by the city of Syracuse will shut down and its four employees will be laid off because federal officials, who had criticized the city's handling of
grants, rejected Syracuse's
application for continued funding.
Just also helped develop the University of Iowa Public Engagement
Grant Program that funded partnerships focused on collaborative interactions and scholarship «
for the mutually beneficial exchange, exploration, and
application of knowledge, information and resources.»
R03s are confusing because the institutes that use this mechanism
for investigator - initiated
grants — 14 that I'm aware of — use it in a variety of ways; some other institutes use the R03 mechanism only
for «special initiatives,» special - purpose
programs publicized through requests
for applications (RFAs).
Although the
program does help scientists communicate with the general public, it is not intended to create
for them an abstract that is immediately useable
for job searches or
grant applications.
In June 2011, the National Institutes of Health's (NIH's) Center
for Scientific Review (CSR) debuted a
program aimed at leveling the playing field — somewhat — by giving young researchers experience on
grant - review panels so that they could see what they look
for in the
grant applications they choose to fund.
But when Sommer proposed a study to test an antibullying
program for children hearing voices, her
grant application was turned down.
The «parent»
program announcement
for unsolicited R01
grant applications is PA -07-070.
Section 1.4 of the SR424 (R&R)
grant application instructions (the link is to a Microsoft Word document) includes explicit instructions
for «interacting» with
program officials.
NSF has taken steps to encourage and enable the use of Grants.gov; in the past 2 years, NSF has reserved a few
programs for applications using Grants.gov alone and written a comprehensive 62 - page manual
for submitting
grant applications through Grants.gov.
But even the
program's $ 320 - million - a-year budget doesn't go far: About 130
applications for such
grants are now stacked up, many worthy but on hold until next year or beyond.
Grants.gov is a repository
for information on all federal
grant - funding
programs, and an increasing number of agencies now require applicants to use Grants.gov's standard online
application forms and to apply through Grants.gov.
NSF cooperates with
Grants.gov on a range of
grant - related matters: NSF posts all of its announcements on
Grants.gov, allows applicants to apply
for funding through
Grants.gov, uses the same government - wide electronic authentication
program as
Grants.gov, and is working with
Grants.gov to develop better
grants - management electronic tools beyond announcements and
applications.
Strømme was the principal investigator
for an incoherent scatter radar facility in Greenland that SRI operates
for NSF when she was invited to come to the agency to clear up a backlog of
grant applications in its aeronomy
program.
For example, we will be able to collaborate with researchers that work on integration of active and passive devices in silicon for telecommunication («Silicon Photonics for Future Systems» EPSRC program grant) or sensing applications («Mid-IR silicon photonics sources, detectors and sensors» funded by the Royal Society) and that will certainly facilitate progress achieved in MIGRATION.&raq
For example, we will be able to collaborate with researchers that work on integration of active and passive devices in silicon
for telecommunication («Silicon Photonics for Future Systems» EPSRC program grant) or sensing applications («Mid-IR silicon photonics sources, detectors and sensors» funded by the Royal Society) and that will certainly facilitate progress achieved in MIGRATION.&raq
for telecommunication («Silicon Photonics
for Future Systems» EPSRC program grant) or sensing applications («Mid-IR silicon photonics sources, detectors and sensors» funded by the Royal Society) and that will certainly facilitate progress achieved in MIGRATION.&raq
for Future Systems» EPSRC
program grant) or sensing
applications («Mid-IR silicon photonics sources, detectors and sensors» funded by the Royal Society) and that will certainly facilitate progress achieved in MIGRATION.»
-- The Secretary shall evaluate and prioritize an
application submitted by a State
for a
grant under the
Program on the basis of --
The mission of the Pharmaceutical Chemistry Facility is to provide MDA Faculty with tool compounds
for in vitro -, in - vivo - and potentially clinical stuides to advance
programs and provide data
for grant applications.
Prof. Dawkins is leading the Australian efforts in the development of a National Plan
for Rare Disease, in concert with this policy position he is also coordinating the Australian partnership in a European Commission Framework
Program 7
applications, RD - CONNECT and concerted action project RARE - BestPractice and a Chief Investigator on the NHMRC Australian European coordination
grants.
In this
program, too, less money will be available in 2015: $ 603 million
for an estimated 340
grants (with a deadline
for applications in March 2015).
In 1996, in response to these concerns, Varmus, then director of NIH, impaneled a group of experienced clinical investigators and academic health center administrators to make recommendations that might guide the NIH toward policy changes to alleviate the concerns in the clinical research community.14 Several of the panel's recommendations have been implemented, including increased support of the General Clinical Research Center budget, expanded support of training in clinical research, and the establishment of NIH - sponsored educational debt relief
programs for clinical investigators.15 - 18 The panel also recommended restructuring of NIH peer review groups so that patient - oriented
grant applications would be evaluated by study sections in which at least half the
grant applications involve patient - oriented research.
Analyses were conducted
for all
applications combined as well as separately
for R01
applications (
grant applications submitted by individual investigators), other R
applications (academic research enhancement awards, exploratory / development
grants, small
grant program, small business awards), and
applications in the K (clinical research training awards
for junior and midcareer faculty), P (
program projects and center
grants), and F (predoctoral and postdoctoral fellowships) series.
Research
Grant Awardees 2018 (Young Investigator and
Program Grants)- 8 Young Investigator
Grants and 23
Program Grants were awarded from a total of 770 letters of intent, 81 of which were selected
for full
application.
For more information on eligibility and to access the
grant application, visit the Project Produce
program page.
For more information on eligibility and to access the
grant application, visit the Salad Bars to Schools
program page.
The 90 - day reassignment took effect on April 26, the WEEA
program's deadline
for new
grant applications.
The
program also helped Krakowsky prepare a portfolio of work from her first year as a teacher, and participants in her section of the
program submitted
applications for mini-grants and used the
grant money
for class projects.
In addition, the administration greatly expanded the TIF
program, which awards
grants to high - need districts to fund performance - based compensation systems, and established a new rule
for winning
applications: proposals would need to differentiate teacher and principal effectiveness, based in significant part on student growth, and create compensation systems that reflected those results.
June 5 — Evaluation
grants: The U.S. Education Department is inviting applications for new awards under its Assessment Development and Evaluation Grants Pr
grants: The U.S. Education Department is inviting
applications for new awards under its Assessment Development and Evaluation
Grants Pr
Grants Program.
The
program is a hybrid: it gives formula
grants to states, but to receive their share of funds (fixed amounts calculated by a formula tied to the states» levels of need) states had to submit
applications specifying in detail how they would set up competitive
grant programs for their districts aimed at helping low - performing, high - poverty schools improve reading instruction in grades K — 3.
A long - awaited inspection of the federal Reading First
program found today that federal education officials may have steered the
grant -
application process
for the $ 1 billion - a-year initiative to ensure that particular reading
programs and instructional approaches were widely used by participating schools, and that others were essentially shut out.
The U.S. Department of Education has announced a new round of
applications for the Supporting Effective Educator Development (SEED)
Grant program.